Comparing the effectiveness of Cureus diffusion-weighted imaging in combination with T2-STIR (short tau inversion recovery) … Background: Perianal fistulas are diagnosed clinically and commonly characterized using magnetic resonance imaging (MRI). It can be attached. .8 hours ago
Comparing the effectiveness of Cureus diffusion-weighted imaging in combination with T2-STIR (short tau inversion recovery) … Background: Perianal fistulas are diagnosed clinically and commonly characterized using magnetic resonance imaging (MRI). It can be attached. .8 hours ago
Fruquintinib combination therapy improves quality-adjusted survival in metastatic colorectal cancer
3D illustration of the colon – Stock.adobe.com The combination of fruquintinib (Fruzakura) and optimal supportive care led to Results from an in-phase post-hoc analysis show that quality-adjusted time to absence of symptoms of disease or toxicity increased when compared with placebo and optimal supportive care in previously treated patients with metastatic colorectal cancer (CRC). The […]
CUREUS Diverticular abscess complicating pregnancy at 18 weeks of gestation in a 30-year-old woman: a case report The combination of pregnancy and diverticulitis is extremely rare, and the management of recurrent and complicated diverticulitis can be difficult.
CUREUS Diverticular abscess complicating pregnancy at 18 weeks of gestation in a 30-year-old woman: a case report The combination of pregnancy and diverticulitis is extremely rare, and the management of recurrent and complicated diverticulitis can be difficult.
BMS Demonstrates Rationale for Opdivo and Yervoy Combination Therapy in First-Line Colorectal Cancer
Photo: California BMS Building Exterior/iStock, hapa bapa Bristol-Myers Squibb on Thursday announced data from the Phase 3 CheckMate-8HW study demonstrating first-line potential for Opdivo (nivolumab) and Yervoy (ipilimumab) combination therapy in metastatic colorectal cancer. . BMS did not provide specific data in Thursday’s announcement, but the company said the combination therapy showed “statistically significant results” […]
A combination that beats standard treatments for metastatic colorectal cancer
October 23, 2023 2 minute read Add topics to email alerts Receive an email when a new article is posted Enter your email address to receive emails when new articles are posted. . ” data-action=”subscribe”> Subscribe Your request could not be processed. Please try again later. If you continue to experience […]
Targeted combination therapy triumphs in KRAS-positive metastatic colorectal cancer
MADRID — The combination of a KRAS G12C inhibitor and an EGFR inhibitor significantly improved progression-free survival (PFS) compared to standard of care in patients with chemotherapy-resistant metastatic colorectal cancer (mCRC). was shown in the randomized phase III CodeBreaK 300 trial. With a median follow-up of 7.8 months, median PFS was 5.6 months for patients […]
New drug combination shows efficacy against early colorectal cancer
Pathologist Erica Hisson (left) and oncologist Pashtun Kashi (right) are two of the scientists involved in a new study demonstrating the effectiveness of a new immunotherapy for colorectal cancer. Weill Cornell Medicine When given before surgery, a combination immunotherapy developed by biotechnology company Agenus destroyed more than 80% of the tumor before it could be […]